4/A

PRIMARY DOCUMENT

Company: FILANA THERAPEUTICS, INC.
Filed: May 23, 2006
Period of Report: February 23, 2006
Accession Number: 0001343264-06-000015

View Document ↗ View on SEC.gov ↗